Bleeding to Birth: Understanding Postpartum Haemorrhage

Research by the  National Library of Medicine found that increased efforts to enhance coordination among healthcare team members in response to PPH have contributed to reduced maternal morbidity. Rapid identification of the cause, controlling the bleeding and initiating treatment is the priority. However, this is not possible without a cohesive interprofessional team that comprises physicians, technicians, nurses, pharmacists, laboratory personnel, and labor and delivery nurses who effectively communicate and coordinate to optimize patient-centred care. 

In a country, like India, where postpartum monitoring is limited typically to the first six weeks, awareness about the cardiovascular risk posed by PPH is vital. The structural health gaps in India often results in iron deficient, anaemic and malnourished persons becoming pregnant, which makes them vulnerable to other complications such as anemia-induced hypertension 

While the primary focus should be reducing PPH, detection and treatment cannot be ignored. 

The E-MOTIVE clinical trial includes a calibrated blood-collection drapes and a rapid treatment bundle (including uterine massage, oxytocics, tranexamic acids, IV fluids, valuation and escalation protocols) that has proven to reduce adverse PPH outcomes by 60%, as per a Lancet Health study.